Back

Beta-blockers remain a key treatment for the management of hypertrophic obstructive cardiomyopathy: con

31 August 2026 (14:30 - 14:45)
Organised by: Logo
Congress Presentation Part of: Great Debate: beta-blockers remain a key treatment for the management of hypertrophic obstructive cardiomyopathy Hypertrophic Cardiomyopathy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Fernando Dominguez

Hospital Universitario Puerta De Hierro Majadahonda, Madrid (Spain)

2 More presentations in this session

Presentation thumbnail
Beta-blockers remain a key treatment for the management of hypertrophic obstructive cardiomyopathy: pro
Doctor C. Coats (Glasgow, GB)
Slides Video
Presentation thumbnail
Beta-blockers remain a key treatment for the management of hypertrophic obstructive cardiomyopathy - discussion
Video

Access the full session

Session thumbnail
Great Debate: beta-blockers remain a key treatment for the management of hypertrophic obstructive cardiomyopathy
Video

The Event

Event poster

ESC Congress 2026

31 August 2026 14:30 CET
You may be interested in
thumbnail
Congress Presentation
Medical therapy for hypertrophic cardiomyopathy
19 May 2025
thumbnail
Congress Presentation
No more beta-blockers for post-myocardial infarction patients with preserved left ventricular ejection fraction: pro
31 August 2026
thumbnail
Congress Session
Ask the Trialists - MAPLE-HCM
30 August 2025
thumbnail
Congress Presentation
Aficamten vs. Metoprolol Monotherapy in Obstructive Hypertrophic Cardiomyopathy According to Pre-Trial Treatment in MAPLE-HCM
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources